Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
27 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/akeso-summit-pd-1xvegf-meets-overall-survival-goal-first-time-lung-cancer-trial
26 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/akesos-2025-interim-results-commercial-sales-reach-new-all-time-highs-302539063.html
26 Aug 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/akeso-scores-twice-pair-phase-3-trials-teeing-regulatory-submission
30 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/akeso-announces-completion-of-first-dosing-in-phase-iii-clinical-trial-of-ivonescimab-pd-1vegf-combination--therapy-for-immunotherapy-resistant-nsclc-302518092.html
28 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nmpa-accepts-snda-for-ivonescimab-in-combination-with-chemotherapy-as-first-line-treatment-for-advanced-squamous-non-small-cell-lung-cancer-302514636.html
23 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/akeso-announces-first-patient-enrollment-in-phase-iii-trial-of-ivonescimab-for-pancreatic-cancer-302512598.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE